Related Experiment Video
Updated: Jul 19, 2026

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
Published on: August 9, 2024
Electrical stimulation in cerebral palsy: a randomized controlled trial
Claire Kerr1, Brona McDowell, Aidan Cosgrove
1Gait Analysis Laboratory, UK.
Insights
Neuromuscular electrical stimulation (NMES) and threshold electrical stimulation (TES) did not significantly improve quadriceps strength or function in children with cerebral palsy (CP). However, TES showed a positive impact on disability, warranting further investigation.
Area of Science:
- Rehabilitation Medicine
- Pediatric Neurology
- Physical Therapy
Background:
- Cerebral palsy (CP) often involves muscle weakness, particularly in the quadriceps.
- Electrical stimulation techniques like NMES and TES are explored as potential therapeutic interventions.
- Assessing the efficacy of these modalities in improving strength and function in children with CP is crucial.
Purpose of the Study:
- To evaluate the effectiveness of NMES and TES in enhancing quadriceps muscle strength in children with CP.
- To determine the impact of NMES and TES on gross motor function and the impact of disability.
- To compare NMES and TES against a placebo in a randomized controlled trial.
Main Methods:
- A randomized placebo-controlled trial involving 60 children with CP (aged 5-16 years).
- Participants were assigned to NMES, TES, or placebo groups.
- Assessments included quadriceps peak torque, gross motor function, and impact of disability at baseline, 16 weeks, and 6-week follow-up.
Main Results:
- No statistically significant differences in quadriceps strength or gross motor function were found between NMES/TES and placebo groups.
- Both NMES and TES showed statistically significant improvements in the impact of disability compared to placebo at the end of treatment.
- TES demonstrated a significant difference in impact of disability versus placebo at the 6-week follow-up.
Conclusions:
- NMES and TES did not demonstrate significant benefits for quadriceps strength or gross motor function in children with CP.
- TES may offer benefits in reducing the impact of disability in children with CP.
- Further research is needed to confirm the utility of NMES/TES as adjunct therapies for ambulatory children with diplegia CP who struggle with traditional strengthening.
Abstract:
A randomized placebo-controlled trial was carried out to investigate the efficacy of neuromuscular electrical stimulation (NMES) and threshold electrical stimulation (TES) in strengthening the quadriceps muscles of both legs in children with cerebral palsy (CP). Sixty children (38 males, 22 females; mean age 11y [SD 3y 6mo]; age range 5-16y) were randomized to one of the following groups: NMES (n=18), TES (n=20), or placebo (n=22). Clinical presentations were diplegia (n=55), quadriplegia (n=1), dystonia (n=1), ataxia (n=1), and non-classifiable CP (n=2). Thirty-four children walked unaided, 17 used posterior walkers, six used crutches, and the remaining three used sticks for mobility. Peak torque of the left and right quadriceps muscles, gross motor function, and impact of disability were assessed at baseline and end of treatment (16wks), and at a 6-week follow-up visit. No statistically significant difference was demonstrated between NMES or TES versus placebo for strength or function. Statistically significant differences were observed between NMES and TES versus placebo for impact of disability at the end of treatment, but only between TES and placebo at the 6-week follow-up. In conclusion, further evidence is required to show whether NMES and/or TES may be useful as an adjunct to therapy in ambulatory children with diplegia who find resistive strengthening programmes difficult.
More Related Videos
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
11:34Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
Published on: January 10, 2013